Recombinant Protein Drugs: A 2025 Update.

López-Laguna H, Parladé E, Favaro MTP, Palacín C, Voltà-Durán E, Ferrer-Miralles N, Corchero JL, Rodríguez-Rodríguez R, Vázquez E, Unzueta U, Villaverde A

Open source

DOI: 10.1007/s40259-026-00783-z
Published: 2026 Jul
Container: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40259-026-00783-z,
  title = {Recombinant Protein Drugs: A 2025 Update.},
  author = {López-Laguna H and Parladé E and Favaro MTP and Palacín C and Voltà-Durán E and Ferrer-Miralles N and Corchero JL and Rodríguez-Rodríguez R and Vázquez E and Unzueta U and Villaverde A},
  year = {2026},
  journal = {BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy},
  doi = {10.1007/s40259-026-00783-z},
  url = {https://doi.org/10.1007/s40259-026-00783-z}
}

RIS

TY  - JOUR
TI  - Recombinant Protein Drugs: A 2025 Update.
AU  - López-Laguna H
AU  - Parladé E
AU  - Favaro MTP
AU  - Palacín C
AU  - Voltà-Durán E
AU  - Ferrer-Miralles N
AU  - Corchero JL
AU  - Rodríguez-Rodríguez R
AU  - Vázquez E
AU  - Unzueta U
AU  - Villaverde A
PY  - 2026
JO  - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
DO  - 10.1007/s40259-026-00783-z
UR  - https://doi.org/10.1007/s40259-026-00783-z
ER  -

APA

H, L., E, P., MTP, F., C, P., E, V., N, F., JL, C., R, R., E, V., U, U., & A, V. (2026). Recombinant Protein Drugs: A 2025 Update.. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. https://doi.org/10.1007/s40259-026-00783-z

Source records

pubmed · retrieved 2026-09-25T11:58:35.209Z